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The Journal of Immunology
Extracellular Lactate: A Novel Measure of T Cell
Proliferation
James T. Grist,*,1 Lorna B. Jarvis,†,1 Zoya Georgieva,† Sara Thompson,†
Harpreet Kaur Sandhu,† Keith Burling,‡ Ashley Clarke,‡ Sarah Jackson,x
Mark Wills,x Ferdia A. Gallagher,* and Joanne L. Jones†
Following activation, T cells rapidly divide and acquire effector functions. This energetically demanding process depends upon the
ability of T cells to undergo metabolic remodeling from oxidative phosphorylation to aerobic glycolysis, during which glucose is
converted into lactate and released extracellularly. In this article, we demonstrate that extracellular lactate can be used to
dynamically assess human T cell responses in vitro. Extracellular lactate levels strongly correlated with T cell proliferation,
and measuring lactate compared favorably with traditional methods for determining T cell responses (i.e., [3H]thymidine incor-
poration and the use of cell proliferation dyes). Furthermore, we demonstrate the usefulness of measuring lactate as a read-out in
conventional suppression assays and high-throughput peptide-screening assays. Extracellular lactate was stably produced over
7 d, and results were reproducibly performed over several freeze–thaw cycles. We conclude that the use of extracellular lactate
measurements can be a sensitive, safe, stable, and easy-to-implement research tool for measuring T cell responses and cellular
metabolic changes in vitro. The Journal of Immunology, 2018, 200: 1220–1226.
T
cells have complex environment-dependent metabolic
profiles, with different T cell subsets using different met-
abolic pathways to fuel their energy requirements (1, 2).
For example, in the presence of oxygen, resting naive and memory
effector T cells (Teffs) primarily metabolize glucose to pyruvate,
which then enters the mitochondrial TCA cycle to produce NADH,
which acts as an electron donor for the electron transport chain,
fueling ATP production via oxidative phosphorylation (OXPHOS)
(2, 3). However, upon stimulation through the TCR and in the
presence of CD28 costimulation, Teffs rapidly switch from OXPHOS
to glycolysis to meet the increased energy and biosynthesis demands
of cellular activation and proliferation (4, 5). This shift causes an
increase in the production and subsequent excretion of lactate by
the cell, which is formed in the cytosol by the action of lactate
dehydrogenase. The upregulation of glycolytic metabolism in Teffs
upon stimulation (even in the presence of oxygen) is akin to the
“Warburg effect” observed in oncological cell lines, through which
cancerous cells increase their lactate output with respect to healthy
tissue to fuel their ever-increasing metabolic demands for rapid
cellular proliferation and expansion (4, 6, 7). In contrast to Teffs, in
normoxic conditions, resting regulatory T cells (Tregs) use fatty
acids, rather than glucose, as their primary energy source, and they
do not switch their metabolism from OXPHOS to aerobic glycol-
ysis following in vitro TCR/CD28 stimulation (8–10).
Given the reliance of activated Teffs onWarburg metabolism, we
set out to explore the usefulness of quantifying extracellular lactate
as a measure of Teff proliferation, under standard laboratory
normoxic conditions. In this article, we show that extracellular
lactate compares favorably with more traditional measures of T cell
proliferation (i.e., thymidine DNA incorporation and cell prolif-
eration dye dilution assessed by flow cytometry). Because naturally
occurring Tregs do not increase their production of lactate in re-
sponse to CD3/CD28 stimulation in vitro, we demonstrate the
usefulness of measuring lactate as a read-out of Treg-mediated
suppression of Teff proliferation. Finally, given the stability of
lactate and the speed and ease with which it can be measured, we
demonstrate the potential of using it in T cell–screening assays
(e.g., as a read-out of CMV exposure status) (11).
Materials and Methods
Cell preparation
Human PBMCs were isolated from the whole blood of healthy donors by
Ficoll centrifugation (Amersham Pharmacia Biotech). All individuals gave
written consent, and the study was approved by a local ethical review
committee (REC: 11/EE/0007). PBMCs were immediately suspended in
culture medium (RPMI 1640; Life Technologies) containing 1% penicillin,
1% streptomycin, and 10% FCS (S5394; Sigma-Aldrich) and adjusted to a
concentration of 106 viable cells per milliliter for subsequent assays. Pan
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T cells were separated magnetically (Pan T Cell Isolation Kit, II; Miltenyi
Biotec), according to the manufacturer’s instructions. CD4+CD252 and
CD8+CD252 Teffs and CD4+CD127lowCD25hi Tregs were isolated from Pan
T cells by FACS (BD Influx), following staining of cell surface CD4, CD8,
CD25, and CD127 with relevant Abs (eBioscience, BD, and BioLegend).
For the CMV study, healthy seropositive and negative donors were
recruited from the National Institutes of Health Research Cambridge
BioResource (HBREC.2014.07). PBMCs were isolated using Lymphoprep
(Axis-Shield, Oslo, Norway) density gradient centrifugation, and the samples
were frozen in 10% DMSO (Sigma-Aldrich) and 90% FBS (Life Technol-
ogies, Thermo Fisher Scientific). Cryopreserved PBMCs were resuscitated
before use in prewarmed DMEM (Sigma-Aldrich) in the presence of 10 U/ml
Benzonase Nuclease (Millipore), followed by a 1-h incubation in warmed
X-VIVO15medium (Lonza) supplementedwith BenzonaseNuclease at 37˚C.
The cells were rested overnight at 37˚C in X-VIVO 15 medium or RPMI
1640 (Sigma-Aldrich) supplemented with penicillin, streptomycin, and 10%
FBS. CMV serostatus of all donors was confirmed by serological assessment
of CMV IgG levels using a Captia Cytomegalovirus (CMV) IgG EIA test
(Trinity Biotech), following the manufacturer’s instructions.
Proliferation assays
CD4+ and CD8+ T cells were cultured in normoxic conditions at 37˚C with
5% CO2, with and without anti-CD3/CD28 stimulation at a cell/bead ratio
of 4:1. At various time points (as indicated in the text), supernatant was
collected and frozen at 220˚C for lactate measurement, and the number of
viable cells at the end of culture was counted using a hemocytometer. To
correlate lactate with proliferation and/or activation, 106 CD4+ cells la-
beled with cell proliferation dye were cultured with and without anti-CD3
stimulation for 6 d. At days 1, 4, and 6, the supernatant was collected for
lactate measurements, and cells were counterstained with live/dead ex-
clusion dye (Zombie NIR; BioLegend) and anti-CD25 and anti-CD69 Abs
(BD) and analyzed by flow cytometry. Lactate measurements were
compared with output for cell proliferation (cell proliferation dye anal-
ysis by flow cytometry; cell proliferation dye high cells were marked as
nonproliferating, and cell proliferation dye low cells were marked as
proliferating). To assess the sensitivity of lactate measurements com-
pared with thymidine incorporation, human PBMCs were cultured at
105–1.5 3 103 cells per well in triplicates, with and without stimulation
using 1 mg/ml plate bound anti-CD3/soluble CD28. Thymidine (25 miC/ml)
was added during the last 18 h of culture, and plates were pulsed on a Becton
Coulter cell harvester at days 3 and 5.
Lactate measurements
Media and supernatant lactate were measured spectrophotometrically using
a Dimension EXL autoanalyzer (Siemens) with Flex reagent cartridges
(product code DF16). In brief, lactate dehydrogenase, NAD, dihydrazine
sulfate, and Tris buffer (40 U and 10, 180, and 100 mmol/l, respectively)
were added to cell-free supernatants. The subsequent exchange of lactate
to pyruvate, captured by the hydrazine compound, is directly proportional
to the change in NAD+ to NADH+ (NADH) concentration measured at
340–383 nm, from which the initial lactate pool size was inferred. Lactate
was not measurable in RPMI 1640 and 10% FBS alone. To assess the
freeze–thaw stability of lactate, 3 3 106 Pan T cells were cultured in
three separate 2-ml wells. All supernatant was removed from the wells at
day 2, and three 50-ml fresh supernatant samples from each well were
analyzed for extracellular lactate. Subsequently, supernatants were also
collected for analysis after one, two, and three freeze–thaw cycles, with
samples left in the freezer for $24 h before thawing.
Treg suppression assay
Teffs (CD4+CD252 T cells) and Tregs were sorted using an Influx cell
sorter (BD), according to their expression of CD4, CD25, and CD127.
Cells were stained with Abs (BD) and sorted as follows: CD3+CD4+
CD25hiCD127low cells were considered Tregs, and CD3+CD4+CD252 cells
were considered CD4+ Teffs. To discriminate between Teffs and Tregs in
the final analysis, Teffs were labeled with 5 mM cell proliferation dye
V450, and Tregs were labeled with 5 mM cell proliferation dye V670 (both
from eBioscience). Teffs were plated at 104 cells per well in triplicate, with
and without Tregs, in RPMI 1640 + 5% human AB serum. For the final
analysis, dead cells were excluded using dead cell exclusion staining
(Zombie NIR; eBioscience), and cells were counterstained with Abs to
CD4. Tregs were titrated in doubling dilutions so that the Treg/Teff ratio
was 1:1 to 1:16. Triplicate control wells of CD4+ T cells without stimulus,
and Tregs, at various dilutions, with and without stimulus, were also
cultured. Treg Suppression Inspector beads (Miltenyi Biotec) were used to
stimulate the assay, according to the manufacturer’s instructions.
Supernatant was removed for lactate analysis, and the cells were ana-
lyzed by flow cytometry at day 6. A lactate suppression index, derived from
lactate and flow results, was calculated using Eq. 1 and 2.
Lactate Suppression Index ¼ TS 2 ðTSup2TReg;StimÞ
TS
ð1Þ
Eq. 1 shows the suppression index calculated from the extracellular
lactate measurements, where TS is the lactate concentration in a stimu-
lated well of 104 Teffs alone (i.e., Treg/Teff ratio of 0:1), TSup is the
lactate concentration with a Treg/Teff ratio of 1:n, where n . 0, and TRef,Stim
is the lactate concentration from the 1:0 well (i.e., 104 stimulated Tregs
alone). The lactate concentration from the 1:0 well was selected because
our preliminary data demonstrated that the lactate suppression index was
not significantly altered by correcting for the exact number of Tregs in
any given well (Supplemental Fig. 2), it would be impractical for most
investigators to set up multiple Treg control wells, and most investigators
report the 1:1 suppression index (showing the other ratios to demonstrate
that suppression can be diluted out).
For analysis of suppression by flow cytometry, live Teffs were gated (see
Fig. 5 for analysis strategy). The flow cytometry suppression index was
calculated by taking the ratio between the proliferating and non-
proliferating populations, as defined by Eq. 2.
Flow Cytometric Suppression Index ¼ T
V 670 Low
Stim 2T
V 670 Low
Sup
TV 670 LowStim
; ð2Þ
where TV 670 LowStim is the proportion of proliferating V670
low Teffs in the
stimulated culture, and TV 670 LowSup is the proportion of proliferating V670
low
Teffs in the stimulated culture with Tregs. The suppression index for each
well was calculated and averaged for each cell set.
CMV peptide response assay
A total of 106 PBMCs from 10 healthy donors were labeled with Cell
Proliferation Dye eFluor 450 (eBioscience) and cultured at 105 cells
per well in triplicate, alone, with soluble anti-CD3 (1 mg/ml), or with
two overlapping peptide pools of CMV immunodominant epitopes (IE1
and gB; 1 mg/ml). The peptide pools were consecutive 15mer peptides
overlapping by 10 aa (libraries synthesized by ProImmune PEPscreen
from previously published sequences) (11, 12). Five donors were naive
to CMV, and five had known previous exposure. Donor status was
assessed using CMV serology, as previously described. Cells were
cultured in a 96-well plate for 6 d. At days 2, 5, and 6, triplicate su-
pernatants were removed from the plate for lactate analysis. At the final
time point (day 6), the cells were collected for flow cytometric anal-
ysis. Total lactate responses were corrected by subtracting the unsti-
mulated pool concentrations from their counterpart anti-CD3– and
CMV peptide–stimulated wells. Lactate data were analyzed in a blin-
ded fashion. Positive wells were those with lactate concentrations $2
SD above the mean lactate concentration in the unstimulated wells. The
lactate assay was set up in parallel with an IFN-g FluoroSpot assay,
using the same PBMCs and peptide pools. The FluoroSpot assay was
processed at day 2, as previously described (13). In brief, the method
involved incubating 2 3 105 PBMCs in precoated FluoroSpot plates
(Mabtech AB) in triplicate with gB or IE1 protein mix peptides (at a
final concentration of 2 mg/ml per peptide) or unstimulated, or in the
presence of anti-CD3 stimulation. The cells and medium were decanted
from the plate, and the assay was developed following the manufac-
turer’s instructions. Developed plates were read using an AID iSpot
reader (Oxford Biosystems) and counted using AID FluoroSpot V7
software (Autoimmun Diagnostika). All data were corrected for back-
ground cytokine production. The positive response cutoff was taken as a
mean of 100 spot forming units per million, as previously determined in
a larger study (13).
Statistical analysis
All flow cytometry data were analyzed in-house with FlowJo (v10.1); all
other data analyses and statistical fitting were performed in-house with
Matlab (MathWorks) or GraphPad (Prism). Where appropriate, ANOVA
and two-tailed t tests were performed to assess for differences between
lactate concentrations in cell well cultures. Coefficient of variation analysis
was performed on freeze–thaw samples. To assess for correlation between
techniques in the suppression assay experiments, a least squares linear fit
was performed. Sensitivity and specificity calculations were performed in
the peptide-response experiments, using serology as the gold standard
measurement technique.
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Results
Activated CD4+ and CD8+ effector cells produce lactate in
normoxic conditions
By day 2, the concentration of lactate measured in supernatant
derived from CD3/CD28-stimulated CD4+ and CD8+ cells cul-
tured in standard laboratory conditions (normoxia at 37˚C with 5%
CO2) was significantly higher than that derived from unstimulated
cells (0.36 0.1 versus 1.96 0.3 and 0.46 0.1 versus 1.466 0.03
mmol/l, respectively, p , 0.01). Between days 2 and 5, lactate
continued to accumulate in the supernatant of stimulated CD4+
and CD8+ cells (0.4 6 0.2 versus 14.16 6 1.82, 0.4 6 0.1 versus
13.7 6 0.4 mmol/l, p , 0.01). Correcting this for the number of
live CD4+ and CD8+ cells at the end of culture revealed an in-
crease in the amount of lactate produced per cell (Fig. 1, p , 0.01
in all cases). Lactate did not accumulate in the supernatant of
unstimulated cells. Flow cytometric analysis confirmed purity and
activation status of the cells (Fig. 1B).
Extracellular lactate correlates well with T cell proliferation
Comparison of the temporal changes in total lactate obtained from the
supernatants of CD3/CD28-stimulated T cells after day 1, 4, and 6 with
flow cytometry data from the same culture well revealed a very strong
correlation between T cell proliferation (defined by cell proliferation
dye dilution) and total lactate (R2 = +0.99, Fig. 2). Cultures of activated
T cells, expressing the early activation marker CD69 and/or CD25 but
not yet proliferating, did not contain high levels of lactate, indicating
that cells undergoing cellular proliferation use glycolysis to a greater
extent than do nondividing activated T cells. Extracellular lactate
concentration was unaffected by cell death (Supplemental Fig. 1).
The sensitivity of lactate as a measure of T cell proliferation is
comparable to thymidine at later time points
Next, we went on to compare the sensitivity of extracellular lactate
as a measure of T cell proliferation with the commonly used
technique of [3H]thymidine incorporation, by culturing between
105 and 1.5 3 103 whole PBMCs with plate-bound anti-CD3 and
soluble anti-CD28 for 3 and 5 d. Thymidine was able to dis-
criminate between unstimulated and stimulated wells at a lower
limit of 6 3 103 PBMCs at days 3 and 5 (p , 0.01), although, at
both time points, 1.25 3 104 PBMCs was the lowest count that
was significantly above the commonly accepted median cpm
cutoff of 1000 (14). Lactate performed less well at day 3 (lower
limit of sensitivity 5 3 104 PBMCs, p , 0.01); however, at day 5,
its sensitivity was comparable to that of thymidine (lower limit of
sensitivity 1.25 3 104, p , 0.01). Because this experiment was
undertaken by stimulating T cells within whole PBMC cultures,
the number of proliferating T cells that can be detected by both
methods will be significantly less than 1.25 3 104. Results from
the sensitivity assay are shown in Fig. 3.
Lactate is stable over multiple freeze–thaw cycles
To determine the stability of lactate after freeze–thawing, 106
T cells were stimulated with anti-CD3/CD28 Dynabeads for
5 d, and the concentration of lactate in aliquots subjected to one
to three rounds of 220˚C freeze–thawing was compared with
the concentration of lactate measured in fresh supernatant.
Analysis of the variance in results revealed highly reproducible
results over a course of three freeze–thaw cycles, with a co-
efficient of variation of 1.77% over four test and retest cycles
(Fig. 4).
Extracellular lactate is as accurate as cell proliferation dye in
determining Treg suppression
In keeping with the literature (10), under normoxic conditions
in vitro, Treg lactate production was relatively low (compared with
Teffs) and did not increase following activation (Supplementary
Fig. 2). Therefore, we went on to explore the usefulness of mea-
suring lactate in a classical Treg-suppression assay in which the
FIGURE 1. Extracellular lactate production by human T cells. (A) CD4+ and CD8+ T cells from two donors were cultured or not for 2 and 5 d with anti-CD3/CD28
Dynabeads, and supernatants were collected in triplicate for analysis of extracellular lactate. Lactate was normalized to viable cell number at each time point. (B) On day 5,
the remaining cells were analyzed by flow cytometry for purity and activation status, as shown by CD4–PE–Cy5 versus CD25-PE staining. Red dots represent unstimulated
cells, and blue dots represent stimulated cells. Unstimulated cell lactate output showed no change between days 2 and 5. *p , 0.01.
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coculture would not be complicated by the increased background
production of metabolites from the regulatory cell pool. Cell pro-
liferation dye dilution was used as the comparator. A representative
flow cytometric analysis is shown in Fig. 5A–C and a lactate
analysis is shown in Fig. 5D. As expected, a titratable effect of
modifying the Treg/Teff ratio was observed using both methods
(Fig. 5C, 5D). Furthermore, calculation and comparison of the
suppression index obtained over multiple suppression assays
revealed a strong correlation between estimates of suppression
obtained from lactate and those obtained by flow cytometry (see
Eqs. 1, 2, R2 = +0.894).
Extracellular lactate provides high specificity and sensitivity in
predicting CMV status
Given the ease with which lactate can be measured, as well as its
sensitivity, stability, and low cost, we went on to test its use-
fulness in interrogating T cell responses to libraries of over-
lapping peptides, a relatively high-throughput technique
commonly used to assess vaccine-induced or other immuno-
logical responses. In brief, cryopreserved PBMCs from 10
healthy individuals (5 known to be CMV seropositive and 5
seronegative) were cultured with IE1 and gB protein CMV
peptide pools; both proteins have been shown to trigger T cell
FIGURE 2. Increased total extracellular lactate correlates with increasing proliferation in stimulated T cell cultures. Cell proliferation dye V450–labeled
T cells were cultured in the presence and absence of anti-CD3/CD28 Dynabeads for 6 d. At days 1, 4, and 6, cell culture supernatants were sampled for
lactate analysis, and cells were analyzed by flow cytometry for proliferation status (cell proliferation dye dilution), as well as counterstained with dead cell
marker (Zombie NIR) and Abs to CD69-allophycocyanin and CD25-PE. (A) The flow gating strategy: dead cells, activated cells, proliferating cells, and
nonproliferating cells were gated. (B) Correlation of total extracellular lactate concentration with T cell proliferation.
FIGURE 3. Comparison of the extracellular lactate proliferation assay with the thymidine-incorporation proliferation assay. Whole PBMCs were
stimulated, in triplicate, with plate-bound anti-CD3/soluble anti-CD28, and supernatants were collected for lactate analysis prior to pulsing cells with
thymidine. To test for sensitivity of the assay, cell numbers were titrated from 105 cells per well to 500 cells per well. (A) Total lactate at days 3 and 5. (B)
Incorporated thymidine (cpm) at days 3 and 5. Lactate data are shown on a linear scale, and thymidine data are shown on a log scale. *p , 0.05 versus
unstimulated control.
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responses in many donors (15). Supernatant lactate production
was compared with IFN-g production, as measured by Fluo-
roSpot. CMV serology was taken as the “gold standard”; CD3
stimulation was included as a positive control. Two donors were
excluded from the analysis owing to a poor anti-CD3 response
in both the lactate and FluoroSpot assays, possibly as a result of
using cryopreserved PBMCs that did not recover well. The
remaining eight donors produced a positive anti-CD3 response
and, therefore, were included in the analysis. Of note, donor 1
produced very little lactate in response to CD3 stimulation (just
above background), whereas their cells made significant amounts of
IFN-g, highlighting the recognized difference between proliferation
(which we have shown correlates strongly with lactate production)
and cytokine secretion (16).
Two independent blinded analysts concluded that donors 6,
7, 8, and 9 were CMV+ from the lactate results; this was in
100% agreement with the serology and FluoroSpot results
after unblinding (Fig. 6). Further analysis of the use of lactate
FIGURE 4. Stability of lactate measurements. Ex-
tracellular lactate is stable over several freeze–thaw
cycles. A total of 33 106 Pan T cells was stimulated in
a 24-well plate with anti-CD3/CD28 Dynabeads for
5 d, and 1 ml of supernatant was collected for analysis.
Total lactate concentration is shown for the same cell
culture supernatant that was repeatedly freeze–thawed.
FIGURE 5. Use of lactate in analyzing a Treg-suppression assay. Treg-suppression assays were performed by coculturing V450 cell proliferation dye–
labeled CD4+ effector T cells with V670 cell proliferation–labeled CD4+CD25hiCD127low Tregs at a 1:1 ratio and doubling dilutions thereafter, in triplicate.
(A) Flow gating strategy of this assay. Live V6702 cells (non-Treg) were taken as effector cells. (B) V450 proliferation dye dilution of the effector T cells
[gated in (A)], with and without Tregs. (C) Percentage suppression of the effector T cell response in the presence of Tregs was calculated (according to the
given equation; see Materials and Methods); suppression by Tregs was titratable. (D) Amount of lactate produced by 104 effectors (0:1), 1 3 104 Tregs
(1:0), and 104 effectors cultured with various numbers of Tregs, corrected for the amount of lactate in the 1:0 well. The black bars represent the calculated
lactate suppression index. (E) Combined data from three suppression assays, correlating the suppression index calculated by flow cytometry with that
calculated by lactate.
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production as a predictor for CMV status revealed 100% specificity
and sensitivity of the technique in comparison with serology and
FluoroSpot.
Discussion
By making use of what is known about the reliance of activated
Teffs on Warburg metabolism, we have demonstrated that extra-
cellular lactate can be used to accurately determine T cell pro-
liferation in vitro, with usefulness across a range of assays.
In this study, we used spectrophotometry to quantify lactate via
the lactate-to-pyruvate exchange reaction catalyzed by lactate
dehydrogenase. This represents a simple, inexpensive, and widely
available approach to assess T cell activation. Cell culture super-
natants can be harvested and stored at 220˚C until the researcher is
ready to process them. There are no additional time-consuming
steps to be performed, and, unlike thymidine, there is no need for
radioactive and potentially carcinogenic material to be handled. The
stability of lactate over multiple freeze–thaw cycles also opens up
the possibility that this method could be used to measure T cell
proliferation post hoc, in stored supernatants collected for other
purposes, such as the measurement of cytokines. Commercial lac-
tate measurement kits are also available as simple-to-use colori-
metric assay kits. These assays were originally designed for the
analysis of tumor cells in culture; however, we suggest that they
could be repurposed to effectively measure T cell metabolism and
proliferation.
In contrast to thymidine, lactate is not a “snapshot” measure of
cell proliferation at a single time point; rather, it is an endpoint/
cumulative measure that provides information regarding the rep-
licative history of the cultured cells. In that regard, it is more akin
to cell proliferation dyes. As a result, lactate is less sensitive than
thymidine at early time points; however, at later time points, its
sensitivity is comparable.
Several other nonradioactive single time point–methods exist
for analyzing T cell proliferation, such as the MTT assay, which
is a metabolism-based colorimetric assay. However, this suffers
from a relative lack of sensitivity and has issues with toxicity. An
MTT assay requires cells to be pulsed with substrate; therefore,
multiplexing this assay with other methods is not possible. In
contrast, lactate accumulates naturally throughout the period of
cell culture, with no need for additional cytotoxic reagents to be
added, so it can be readily used alongside other assays (e.g.,
cytokine analysis or flow cytometry). Through costaining with
Abs against additional cellular markers, flow cytometric methods
enable significant additional details about the nature of the cel-
lular response to be interrogated; however, flow cytometry is
labor intensive and relatively costly. Furthermore, the level of
detailed information that flow cytometry can provide is not al-
ways required.
FIGURE 6. Screening of blood donors
for responses to CMV peptides. Data from
PBMCs of eight healthy donors, cultured
with soluble anti-CD3 or one of two dif-
ferent CMV peptide pools (IE1 and gB;
1 mg/ml). PBMCs were plated at 105 cells
per well in triplicates in 96-well plates.
(A) IFN-g ELISPOT was performed at
48 h, and a mean spot-forming unit per
million . 100 was taken as a positive
response. Extracellular lactate was mea-
sured in cell culture supernatants at days 2
and 5. (B) Day-5 positive total lactate
concentrations. All four seropositive do-
nors were identified as responders to one
or both peptides by both methods.
Table I. Summary of cell culture analysis techniques
Name
Type of
Measurement
Approximate Cost perWell
($)
Radiation
Exposure Experimental Time Experimental Steps
Lactate Cumulative 1 No Approximately
30 min
Removal of cell culture supernatants
Spectrophotometry
Flow cytometry Cumulative 6 No Several hours Cell proliferation dye labeling during
assay set-up
Harvesting and counterstaining of
cells with Abs
Flow cytometry acquisition and
analysis
Thymidine Snapshot 1 Yes .12 h Pulsing of cells with thymidine
(usually overnight)
Cell harvesting
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We have demonstrated that, under standard laboratory normoxic
conditions, extracellular lactate strongly correlates with T cell
proliferation (R2 = +0.99). We assume that this would not be the
case if cells were to be cultured in hypoxic conditions, in which
proliferating and nonproliferating cells would use glycolysis to
satisfy their energy needs (17).
Although the literature on Treg metabolism is complex, and
recent studies have demonstrated that the in vivo environment may
influence their metabolic requirements, it is generally accepted that
in vitro FOXP3+ Tregs rely more on fatty acid oxidation and do
not undergo glycolysis. In addition, it has recently been suggested
that FOXP3, the key transcription factor in Tregs, actively turns
off glycolysis (10, 17–19). In keeping with this, we have shown
that, in normoxic conditions, in vitro–cultured Tregs produce
relatively little lactate and that production does not increase with
activation. Given this, we reasoned that lactate may be a partic-
ularly attractive method for assessing Treg suppression of Teffs,
because the cocultures would not be complicated by significant
background production of metabolites from the regulatory cell
pool. Indeed, this was demonstrated to be the case, with sup-
pression of lactate production showing strong correlation with
suppression of T cell proliferation, as determined by cell prolif-
eration dye and flow cytometry (R2 = +0.894). As described in
Materials and Methods, the amount of lactate produced by Teffs
in the presence of Tregs was corrected by the amount of lactate
produced by 104 stimulated Tregs (regardless of the actual number
of Tregs in any given well), raising the possibility that our method
may overestimate suppression at the lower Treg/Teff ratios.
However, this effect was found to be small and was not statisti-
cally significant. Given its simplicity, sensitivity, stability, and cost
effectiveness, we have shown that lactate could be useful in in-
terrogating T cell responses in high-throughput assays, such as
measuring responses to libraries of overlapping peptides to assess
vaccine-induced or other immunological responses. To assess this,
we examined its usefulness in identifying CMV-seropositive
healthy individuals and found it to be 100% sensitive and specific
in the sample tested. A summary of the techniques used in this
article, including their cost and time required for analysis, is
shown in Table I.
In conclusion, we believe that the measurement of extracellular
lactate is a safe, reliable, sensitive, fully quantifiable, and cost-
effective method for analyzing T cell proliferative responses
in vitro that can complement, and in selected circumstances re-
place, more traditional methods. In particular, we suggest that
lactate may prove to be particularly useful in high-throughput
screening assays.
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